Home » Topics » Regulatory

Regulatory
RSS

FDA approves Xgeva for hypercalcemia of malignancy

Dec. 9, 2014

Signifor approved in E.U. to treat acromegaly

Nov. 24, 2014

European Commission approves Duaklir Genuair for COPD

Nov. 24, 2014

FDA grants accelerated approval to Trumenba for prevention of meningococcal meningitis B

Oct. 30, 2014

FDA approves Baxter's Obizur for acquired hemophilia A

Oct. 27, 2014

FDA approves two idiopathic pulmonary fibrosis drugs ahead of schedule

Oct. 16, 2014

FDA approves netupitant/palonosetron combination for CINV

Oct. 13, 2014

FDA approves Harvoni for hepatitis C

Oct. 13, 2014

Approval in Japan for manufacturing and distribution of ripasudil hydrochloride hydrate

Oct. 1, 2014

FDA approves Otezla for the oral treatment of plaque psoriasis

Sep. 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...